On the other hand, the SR tumours from the mice treated with compound 9a showed significantly lower levels of cyclin D1 and three HCC biomarkers (α-fetoprotein, survivin and glypican 3) than those from the vehicle control-treated mice (Fig. 5d). This evidence concerns the gene BIRC5 and hepatocellular carcinoma.